SynthesisFrontiers in cardiovascular medicine2025

Effects of subcutaneous or oral semaglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Sihua Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.